Anúncio
Anúncio
AXSM
Axsome Therapeutics, Inc
178.59
USDPatrocinado
-4.05
-2.22%
02 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
179.00
+0.41
+0.23%
Relatórios de Lucros AXSM
Rácio de surpresa positiva
AXSM separação 20 de 40 últimas estimativas.
50%
Próximo Relatório
Data do Próximo Relatório
16 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$191.46M
/-$0.47
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+11.97%
/-50.00%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+61.21%
/-69.48%
Axsome Therapeutics, Inc earnings per share and revenue
On 03 de nov. de 2025, AXSM reported earnings of -0.94 USD per share (EPS) for Q3 25, missing the estimate of -0.88 USD, resulting in a -6.47% surprise. Revenue reached 170.99 milhão, compared to an expected 165.80 milhão, with a 3.13% difference. The market reacted with a +0.56% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 22 analistas forecast an EPS of -0.47 USD, with revenue projected to reach 191.46 milhão USD, implying an diminuir of -50.00% EPS, and aumentar of 11.97% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Holdings Inc. Common Stock
Report Date
22 de dez. de 2025 Para Q4 25
Estimativa
-$0.57
Real
-$0.73
Surpresa
-25.95%
Outlook Therapeutics, Inc. Common Stock
Report Date
19 de dez. de 2025 Para Q4 25
Estimativa
-$0.25
Real
-$0.19
Surpresa
+26.47%
Citius Oncology, Inc. Common Stock
Report Date
23 de dez. de 2025 Para Q4 25
Estimativa
-$0.12
Real
-$0.06
Surpresa
+50.98%
FAQ
What were Axsome Therapeutics, Inc's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Axsome Therapeutics, Inc reported EPS of -$0.94, missing estimates by -6.47%, and revenue of $170.99M, 3.13% above expectations.
How did the market react to Axsome Therapeutics, Inc's Q3 2025 earnings?
The stock price moved up 0.56%, changed from $134.99 before the earnings release to $135.75 the day after.
When is Axsome Therapeutics, Inc expected to report next?
The next earning report is scheduled for 16 de fev. de 2026.
What are the forecasts for Axsome Therapeutics, Inc's next earnings report?
Based on 22
analistas, Axsome Therapeutics, Inc is expected to report EPS of -$0.47 and revenue of $191.46M for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio